MUTYH and cancer: Recent findings have led to the proposal of the term MUTYH‐associated tumor syndrome (MATS) to more accurately reflect the broad cancer spectrum observed in carriers of germline MUTYH mutations, beyond the classical colorectal phenotype of MAP.